Mirvaso

Active Ingredient(s): Brimonidine
FDA Approved: * August 23, 2013
Pharm Company: * GALDERMA LABS
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Mirvaso Overview

Brimonidine is a drug, used as eye drops under the brand names Alphagan and Alphagan-P to treat open-angle glaucoma or ocular hypertension, as a gel, Mirvaso, for facial skin redness in rosacea, and in tartrate formulation, beginning in July 2018, as an ophthalmic vasoconstrictor, sold by Bausch and Lomb under the brand name Lumify, also as eye drops, in 0.025% solution.[citation needed] It acts via decreasing synthesis of aqueous humor, and increasing the amount that drains f...

Read more Mirvaso Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Brimonidine

Recent Mirvaso Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Brimonidine
  • Drops: 0.2%
  • Gel: 0.33%
  • Solution: 0.15%, 0.2%
  • Solution/drops: 0.025%, 0.1%, 0.10%, 0.15%, 0.2%, 0.20%, 0.5%, 0.50%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Mirvaso: (1 result)

Sorted by National Drug Code
  • 0299-5980 Mirvaso 5 mg/g Topical Gel by Galderma Laboratories, L.p.

Other drugs which contain Brimonidine or a similar ingredient: (8 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 11 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA